Galectin-3 as a Potential Target to Prevent Cancer Metastasis

Clinical Medicine Insights: Oncology - New Zealand
doi 10.4137/cmo.s29462
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Lipocalin 2: A Potential Therapeutic Target for Breast Cancer Metastasis

OncoTargets and Therapy
OncologyPharmacology
2018English

The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Cancer Metastasis: A Therapeutic Target

Journal of Oncology
Oncology
2019English

Galectin-3 Is a Potential Mediator for Atherosclerosis

Journal of Immunology Research
MedicineAllergyImmunology
2020English

Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface

Cancer Research
Cancer ResearchOncology
2009English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

The Microbiome as a Possible Target to Prevent Celiac Disease

Expert Review of Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy